Gravar-mail: Corrigendum to “PI3K Inhibition Augments the Therapeutic Efficacy of a 3a–aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256–266.e5]